Company news
Guobang Pharma Ltd. news in 2025
Guobang Pharma Ltd.'s news releases, calls and decks from 2025, newest first.
Announcement on the Completion of Non-Trading Transfer and Purchase under the Phase II Employee Stock Ownership Plan
December 15, 2025
Announcement on Progress in Implementing Phase II Employee Stock Ownership Plans
December 11, 2025
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
November 24, 2025
Announcement on Convening the Q3 2025 Performance Briefing
November 20, 2025
Announcement on Completing Term Change of Board of Directors and Appointing Senior Management Members and Securities Affairs Representative
November 6, 2025
Notice on Convening the 1st Extraordinary General Meeting in 2025
October 16, 2025
Announcement on Completion of Share Transfer of Ownership by Company Shareholders under Shareholder Agreement
September 29, 2025
Indicative Announcement on Proposed Share Transfer via Agreement by Company Shareholder to Introduce Strategic Investor and Related Change in Interests
August 20, 2025
Announcement on Convening the 2025 Semi-annual Performance Briefing
August 8, 2025
Indicative Announcement on Expiration of the Lock-up Period of Phase I Employee Stock Ownership Plan
August 5, 2025
2025 Semi-annual Report
July 29, 2025
Announcement on the Wholly-owned Subsidiary's Participation in the Establishment of the Equity Investment Fund and Completion of the Private Equity Fund Filing
July 3, 2025
Announcement on Wholly-owned Subsidiary's Product Tulathromycin Passing European Union GMP Certification
June 23, 2025
Announcement on Progress of Wholly-owned Subsidiary Participating in the Establishment of Equity Investment Fund
June 17, 2025
Announcement on Implementation of Dividend Distribution for 2024
June 5, 2025
Announcement on Adjusting Distribution Amount per Share in 2024 Annual Profit Distribution Plan
May 28, 2025
Announcement on Resolution of the 2024 Annual General Meeting
April 25, 2025
Announcement on Wholly-owned Subsidiary Participating in the Establishment of Equity Investment Fund
April 21, 2025
Report for Q1 2025
April 15, 2025
Announcement on Resolution of the 12th Meeting of the 2nd Board of Directors
March 27, 2025
Announcement on Receiving the Letter of Commitment for Buyback Loan
March 20, 2025
Announcement on Shareholding of Top 10 Shareholders and Top 10 Holders of Shares Without Restrictions Concerning Repurchase
March 14, 2025
Announcement on Repurchasing Shares through Call Auction
March 10, 2025
Announcement on Wholly-owned Subsidiary Receiving Notice of Approval for Marketing Application of Chemical APIs
February 27, 2025
Announcement on Completion and Implementation Results of Repurchase
January 24, 2025
Announcement on Extension of Share Lockup Period by Controlling Shareholder, Actual Controller and Other Shareholders
January 21, 2025
Announcement on Progress in Repurchasing Shares through Call Auction
January 2, 2025